Clinical Trials Browser

Adenocarcinoma × regorafenib × Clear all

NCT04879368 2025-07-17

INTEGRATEIIb

Phase 3 Active not recruiting

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT03722108 2023-10-16

REGIRI

Phase 1/2 Terminated

Adenocarcinoma

NCT02773524 2022-01-13

INTEGRATEIIa

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT01929616 2019-06-25

RegARd-C

Phase 2 Completed

Adenocarcinoma